Invited commentary: Hormone therapy risks and benefits - The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis
Worldwide evidence on menopausal hormone therapy shows that it does not reduce coronary heart disease (CHD) risk and that it increases the risks of breast cancer, stroke, and venous thromboembolism. These risks are not offset by reductions in hip fracture risk. Consequently, the Food and Drug Administration and other drug regulatory authorities agree that hormone therapy should be used chiefly for short-term relief of menopausal symptoms. Continuing speculation relates to the "postmenopausal...[Show more]
|Collections||ANU Research Publications|
|Source:||American Journal of Epidemiology|
|01_Banks_Invited_commentary:_Hormone_2009.pdf||91.11 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.